This is the pattern I keep running into in practice: clinical demand outpaces the systems meant to govern it, and the clinicians closest to patients are left interpreting ambiguity in real time, with no monograph, no FDA-approved product, and often no clear precedent, while still being accountable for the outcome
Formononetinpiperinephospholipid complex: enhancement of anti-osteoporotic activity and bioavailability in bone marrow in rats
This protein, in turn, controls and regulates the inflammatory processes [11]
Of course, our study has some limitations, including that most of the included articles showed high bias and heterogeneity which makes it difficult to reach a definitive conclusion about the effects of carnitine
P.BhatiaA.BuvanendranA.SchwenkE